GB0424994D0 - Dosage form - Google Patents

Dosage form

Info

Publication number
GB0424994D0
GB0424994D0 GB0424994A GB0424994A GB0424994D0 GB 0424994 D0 GB0424994 D0 GB 0424994D0 GB 0424994 A GB0424994 A GB 0424994A GB 0424994 A GB0424994 A GB 0424994A GB 0424994 D0 GB0424994 D0 GB 0424994D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0424994A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GB0424994A priority Critical patent/GB0424994D0/en
Publication of GB0424994D0 publication Critical patent/GB0424994D0/en
Ceased legal-status Critical Current

Links

GB0424994A 2004-11-11 2004-11-11 Dosage form Ceased GB0424994D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0424994A GB0424994D0 (en) 2004-11-11 2004-11-11 Dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424994A GB0424994D0 (en) 2004-11-11 2004-11-11 Dosage form

Publications (1)

Publication Number Publication Date
GB0424994D0 true GB0424994D0 (en) 2004-12-15

Family

ID=33523616

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0424994A Ceased GB0424994D0 (en) 2004-11-11 2004-11-11 Dosage form

Country Status (1)

Country Link
GB (1) GB0424994D0 (en)

Similar Documents

Publication Publication Date Title
IL251539A0 (en) Unitary pharmaceutical dosage form
IL182615A0 (en) Pharmaceutical compounds
GB0419849D0 (en) Pharmaceutical combination
GB0513984D0 (en) Dosage form
GB0427455D0 (en) Dosage forms
IL181229A0 (en) Noncardiotoxic pharmaceutical compounds
GB0423964D0 (en) Dosage form
IL180487A0 (en) Medicament
EP1753400A4 (en) Ziprasidone dosage form
EP1764102A4 (en) Quinolone-containing medicinal composition
ZA200605666B (en) Solid dosage form
GB0512453D0 (en) Dosage unit
GB0428554D0 (en) Pharmaceutical compounds
GB0424742D0 (en) Pharmaceutical compounds
GB0424994D0 (en) Dosage form
GB0411047D0 (en) Dosage form
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
GB0417777D0 (en) Pharmaceutical combination
GB0315019D0 (en) Dosage form
GB0522989D0 (en) Dosage form
HU2883U (en) Medicinal chair-cushion
GB0403149D0 (en) Medicament
GB0408878D0 (en) Medicinal compounds
GB0418567D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)